Horanzy v. Vemma Nutrition Co.

87 F. Supp. 3d 341, 2015 U.S. Dist. LEXIS 21906, 2015 WL 728379
CourtDistrict Court, N.D. New York
DecidedFebruary 18, 2015
DocketNo. 7:14-CV-1296
StatusPublished
Cited by2 cases

This text of 87 F. Supp. 3d 341 (Horanzy v. Vemma Nutrition Co.) is published on Counsel Stack Legal Research, covering District Court, N.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Horanzy v. Vemma Nutrition Co., 87 F. Supp. 3d 341, 2015 U.S. Dist. LEXIS 21906, 2015 WL 728379 (N.D.N.Y. 2015).

Opinion

MEMORANDUM — DECISION and ORDER

DAVID N. HURD, District Judge.

I. INTRODUCTION

Named plaintiff John Horanzy (“Horan-zy” or “plaintiff’) filed this putative class action against defendants Vemma Nutrition Company (“Vemma”); its President [344]*344and Chief Executive Officer, Benson K. Boreyko (“Boreyko”); and its “Chief Science Officer,” Yibing Wang (‘Wang”).

Horanzy alleges that Vemma, Boreyko, and Wang (collectively “defendants”) are responsible for marketing, advertising, and selling a line of liquid dietary supplements based on false and misleading health claims in violation of the federal Magnu-son-Moss Warranty Act. Plaintiff also brings related claims under provisions of New York’s General Business Law as well as common law claims for unjust enrichment, negligent and fraudulent misrepresentation, and breach of express warranty.

Defendants have moved to transfer venue to the District of Arizona pursuant to 28 U.S.C. § 1404(a). The motion has been fully briefed.1 Oral argument was heard in Utica, New York on February 13, 2015. Decision was reserved.

II. BACKGROUND

Vemma, an Arizona corporation headquartered in Tempe, Arizona, markets and sells a line of liquid dietary supplements containing a “clinically studied” and “doctor formulated” blend of ingredients based on a Southeast Asian fruit called “mangosteen.” Compl. ¶¶ 1-2, 12. Defendants’ product packaging and labeling, as well as its marketing and advertising campaign, claims that these mangosteen-infused products provide a number of specific health benefits, including increasing a consumer’s immune response and improving overall health. Id. ¶2. Plaintiff alleges that the “consensus of published research” confirms that these health claims are clearly false. Id.

Vemma’s product line is manufactured in Arizona, California, Missouri, and Tennessee; its products are tested in Arizona, Illinois, Massachusetts, Michigan, and Wisconsin. Tengan Deck, ECF No. 17-1, ¶ 12. Vemma has no offices, property, or other presence in New York. Id. ¶ 14. In fact, Vemma does not even sell its products through traditional retail outlets in any of these states. Compl. ¶ 12.

Rather, Vemma employs a “direct sales” distribution model — it offers products through its website to ‘Vemma Members,” who must first agree to the terms of a Member Agreement found on the corporation’s website or by physically completing a written application.2 Tengan Decl. ¶¶ 3, 5. Once enrolled, Vemma Members can order the product for consumption and/or receive commissions by re-selling the products and referring new members for enrollment. Compl. ¶¶ 79, 83.

Horanzy alleges that this “direct sales” or “multi-level marketing” sales’ structure is an integral part of the success of Vem-ma’s fraudulent enterprise. Compl. ¶ 79. Plaintiff alleges that Boreyko, Vemma’s CEO, previously engaged in the same sort of deceptive marketing and sales as head of a corporation called New Vision International, which was barred from selling a group of similarly products by the Federal Trade Commission (“FTC”) in 1999. Id. ¶¶ 73, 77. Plaintiff alleges that when the FTC enjoined New Vision International from engaging in these fraudulent business practices, Boreyko merged that cor[345]*345poration with Vemma as a way to continue operations. Id. ¶¶ 77-78. Plaintiff claims that defendants employ the so-called “independent” member-distributor model in an attempt to insulate themselves from liability created by the “ridiculous” health claims they make. Id. ¶ 79. To that end, plaintiff alleges defendants provide manuals and other materials to these Vemma Members that instructs them to use false and misleading health claims and testimonials in “enrolling” new members and reselling the product. Id. ¶ 3.

Horanzy is a resident of Colton, New York. Compl. ¶ 11. Plaintiff alleges that he made several individual, in-person purchases of Vemma products from a “Vemma Member” living in New York State. Id. Plaintiff alleges that the products he purchased and consumed did not result in the health benefits that Vemma claimed. Id. Finally, plaintiff alleges that he is not a “Vemma Member” since he never enrolled -in the program, did not make any purchases from the website, and did not agree to the Member Agreement online or in writing. Id.

Horanzy seeks to represent a class of plaintiffs defined as “all persons in the United States who purchased one or more of the Products.” Compl. ¶ 123. He further seeks to represent a subclass of plaintiffs defined as “all [c]lass members who are New York residents or who purchased the Products within the State of New York.” Id. ¶ 124.

III. DISCUSSION

A. Consideration of Defendants’ Reply

Shortly before oral argument in this matter, Horanzy’s counsel submitted a letter brief raising two, related issues. See ECF No. 28. First, counsel formally objected to defendants’ reply memorandum since, as a general matter, this District’s local rules prohibit reply submissions on non-dispositive motions. N.D.N.Y.L.R. (“Local Rule”) 7.1(b)(2). Second, counsel points out that defendants’ reply, which purports to “withdraw” their motion to dismiss, was submitted a mere eleven days prior to the scheduled return date even though these same Local Rules require a party “who does not intend to pursue” a motion to notify the Court and other parties no less than fourteen days before the scheduled return date. Local Rule 7.1(b)(3) (emphases added).

Of course, there can be no dispute that certain aspects of defendants’ original motion, specifically the portion seeking dismissal of Horanzy’s complaint pursuant to the doctrine of forum non conveniens, would have been dispositive if granted. And certainly plaintiffs counsel would not dispute that the Local Rules permit reply submissions on dispositive motions. See Local Rule 7.1(b)(1). The primary basis for plaintiffs objection on this point, then, is that defendants’ “withdrawal” of their forum non conveniens argument — accomplished by providing notice in a reply memorandum submitted in accordance with the Local Rules regulating dispositive motion practice — rendered the reply submission itself impermissible.

Here, and as made clear at oral argument, defendants’ reply memorandum will be considered. Notwithstanding the compulsory language recited above, it is well settled that a “district court has broad discretion to determine whether to overlook a party’s failure to comply with local rules.” D.H. Blair & Co., Inc. v. Gottdiener, 462 F.3d 95, 108 n. 2 (2d Cir.2006) (quoting Holtz v. Rockefeller & Co., Inc., 258 F.3d 62, 73 (2d Cir.2001)). Assuming Horanzy’s rather convoluted claim regarding the timing of defendants’ reply submissions is meritorious, the favorable exercise [346]*346of such discretion is appropriate here. Defendants’ moving papers put plaintiff on notice that they sought to dismiss or, alternatively, transfer venue.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ward v. Stewart
133 F. Supp. 3d 455 (N.D. New York, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
87 F. Supp. 3d 341, 2015 U.S. Dist. LEXIS 21906, 2015 WL 728379, Counsel Stack Legal Research, https://law.counselstack.com/opinion/horanzy-v-vemma-nutrition-co-nynd-2015.